COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer

Purpose: Collectin subfamily member 12, a transmembrane scavenger receptor C-type lectin, is aberrantly expressed in various cancers. However, its physiological role in gastric Cancer remains somewhat unclear. This study aimed to investigate the Collectin subfamily member 12 expression pattern in human gastric Cancer and its role in gastric Cancer progression.

Methods: The Kaplan-Meier method was used for survival analysis. The univariate and multivariate COX proportional hazards regression models were used to identify independent predictors for progression-free survival and overall survival. The effects of Collectin subfamily member 12 on gastric Cancer cell proliferation, migration, invasion, and Apoptosis were detected through the cell counting kit-8 assay, colony formation assay, wound healing assay, transwell assay, and flow cytometry analysis, respectively. Additionally, the correlation between Collectin subfamily member 12 expression and immune cell infiltration was analyzed through bioinformatics.

Results: Collectin subfamily member 12 was highly expressed in advanced gastric Cancer (T3-T4, pathologic stage III-IV). High Collectin subfamily member 12 expression was correlated with a worse progression-free survival and overall survival in the gastric Cancer patients. In vitro, cell line studies revealed that Collectin subfamily member 12 promoted gastric Cancer cell proliferation, migration, and invasion and inhibited gastric Cancer cell Apoptosis. The bioinformatics analysis further demonstrated that the Collectin subfamily member 12 expression level positively correlated with infiltration of several immune cells, such as M2 macrophages, dendritic cells, neutrophils, and regulatory T cells, suggesting that Collectin subfamily member 12 may also play a role in suppressing tumor immune response in gastric Cancer.

Conclusions: Collectin subfamily member 12 was identified as a novel predictive marker and target for the clinical treatment of gastric Cancer.

COLEC12; gastric cancer; invasion; migration; prognosis; tumor-infiltrating lymphocytes.